Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. B. Diette, C. B. Cangialose, T. G. Knight, Y. C. Yeh, T. F. Goss, J. P. Harnett, J. Wilson (Baltimore, Gaithersburg, New York). Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB). Eur Respir J 2003; 22: Suppl. 45, 3522

Member's Comments

No comment yet.

Related content which might interest you: Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 928-933 Year: 2001 Efficacy and safety of various antimicrobial regimens in the treatment of acute exacerbations of chronic bronchitis Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 Why short-term antibiotic use in AECB may influence long-term outcomes Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Telithromycin is effective in the treatment of patients with acute exacerbations of chronic bronchitis and risk factors for morbidity Source: Eur Respir J 2002; 20: Suppl. 38, 545s Year: 2002 Correlation between eradication of infecting organism on days 3-5 of antibiotic therapy and clinical cure in patients with acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019 Efficacy of levofloxacin (LVF) in the treatment of acute exacerbations of chronic bronchitis (AECB) in patients with risk factors Source: Annual Congress 2003 - Acute exacerbations of asthma and COPD Year: 2003 Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations Source: Eur Respir Rev 2006; 15: 47-51 Year: 2006 Cost analysis for inpatient therapy in elderly patients with acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 661s Year: 2004 CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions Source: Eur Respir J, 53 (5) 1802014; 10.1183/13993003.02014-2018 Year: 2019 Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Speed of recovery after antibiotic treatment of acute exacerbations of moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002 Efficacy and safety of moxifloxacin in the outpatient treatment of exacerbations of chronic obstructive pulmonary disease Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Effects on health care utilisation of early pulmonary rehabilitation on hospitalisation for an acute exacerbation of chronic respiratory disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Factors associated with higher direct costs of exacerbations of chronic bronchitis and COPD in primay care Source: Eur Respir J 2004; 24: Suppl. 48, 410s Year: 2004